Media & Advertising
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
Have an interest in this Story?
Sign Up for Real-Time email updates
August 01, 2013
/PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and six months ended June 30, ...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
Cameron LNG Liquefaction Project Breaks Ground In Louisiana
Updated: Harwood Feffer LLP Announces Investigation of Bankrate, Inc.
Federal Judge awards an additional $13.1 million in punitive damages in trade secrets
Study Finds Significant Increase in Rates of Type 1 Diabetes Among U.S. Non-Hispanic
The Chicago Transit Authority Partners with Titan to Pilot Beacon Technology
- Big News Network
Sergio Waldeck, MBA
Director of Financial Planning and Analysis
Senior Vice President
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.